Study finds experimental drug slows progression of Alzheimer's disease

There's new hope for those in the early stages of Alzheimer's. A recent study found that an experimental drug from pharmaceutical company Eli Lilly can slow the progression of Alzheimer's by about 35%. However, the new drug also comes with an increased risk of side effects.

Host Celeste Headlee discusses the benefits and the risks with STAT's Adam Feuerstein.